Assessing the Value of Cancer Immunotherapies
Abstract
The new classes of cancer immunotherapies hold great, exciting clinical promise across a number of cancer types, with the potential of extending the lives of patients who previously had no options. However, these drugs also come with an eye-watering sticker price, with courses of treatment costing hundreds of thousands of dollars.